跳到主要內容

Dube Eric M 的 Form 4 申報

Travere Therapeutics, Inc.TVTX,2026/9/17 申報

申報編號
0001763494-26-000007
申報時間
2026/9/17 21:31 ET
交易日
2026/9/15-9/17
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 11 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $2,539 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Dube Eric MCIK 0001763494董事、高階主管(執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/9/15Common StockM行使選擇權取得+95,666$23.34+$2,232,844.44528,552直接
2026/9/15Common StockS賣出處分−63,498$61.99F2−$3,936,526.76465,054直接
2026/9/15Common StockS賣出處分−28,796$62.66F3−$1,804,222.02436,258直接
2026/9/15Common StockS賣出處分−3,102$63.64F4−$197,421.83433,156直接
2026/9/15Common StockS賣出處分−270$65.31−$17,633.7432,886直接
2026/9/16Common StockM行使選擇權取得+195,841$23.34+$4,570,928.94628,727直接
2026/9/16Common StockS賣出處分−99,716$63.26F5−$6,307,964.36529,011直接
2026/9/16Common StockS賣出處分−96,125$63.64F6−$6,117,289.26432,886直接
2026/9/17Common StockM行使選擇權取得+108,493$23.34+$2,532,226.62541,379直接
2026/9/17Common StockS賣出處分−101,691$64.59F7−$6,567,875.94439,688直接
2026/9/17Common StockS賣出處分−6,802$64.95F8−$441,795.34432,886直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/9/15Common StockM行使選擇權處分−95,666$0.00$0304,334直接
2026/9/16Common StockM行使選擇權處分−195,841$0.00$0108,493直接
2026/9/17Common StockM行使選擇權處分−108,493$0.00$00直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The weighted average sale price for the transaction reported was $61.9945, and the range of prices were between $61.405 and $62.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

表 I 有 1 筆交易的價格引用這則附註。

F3

The weighted average sale price for the transaction reported was $62.6553, and the range of prices were between $62.41 and $63.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

表 I 有 1 筆交易的價格引用這則附註。

F4

The weighted average sale price for the transaction reported was $63.6434, and the range of prices were between $63.45 and $63.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

表 I 有 1 筆交易的價格引用這則附註。

F5

The weighted average sale price for the transaction reported was $63.2593, and the range of prices were between $62.51 and $63.505. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

表 I 有 1 筆交易的價格引用這則附註。

F6

The weighted average sale price for the transaction reported was $63.6389, and the range of prices were between $63.51 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

表 I 有 1 筆交易的價格引用這則附註。

F7

The weighted average sale price for the transaction reported was $64.5866, and the range of prices were between $63.84 and $64.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

表 I 有 1 筆交易的價格引用這則附註。

F8

The weighted average sale price for the transaction reported was $64.9508, and the range of prices were between $64.84 and $65.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)